Lymphomas.
Kwak
L W
LW
Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research and Development Center, MD.
DeVita
V T
VT
Longo
D L
DL
D002648:Child; D006689:Hodgkin Disease / Q000473:pathology / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy; D016410:Lymphoma, T-Cell, Cutaneous / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis